Monthly Archives: September 2016

Newer antidepressants don’t appear to carry an increased risk of cardiovascular events, according to findings from a British cohort study. As a class, selective serotonin reuptake inhibitors (SSRIs) didn’t hike the individual risks of arrhythmia, stroke, or MI, Carol Coupland, … Continue reading →

Deep brain stimulation (DBS) may be effective for relieving symptoms in treatment-resistant depression, Dutch researchers reported. A significant decrease in depressive symptoms was observed in 10 of 25 patients given DBS of the central anterior limb of the internal capsule … Continue reading →

Growth charting the brain’s networks could provide a novel way to detect neurocognitive abnormalities such as impaired attention functioning in youth, researchers said. Resting-state functional neuroimaging of a small cohort of youth revealed deviations from normal patterns of brain maturation … Continue reading →

Mindfulness-based cognitive therapy (MBCT) was effective at reducing risk of relapse in patients with recurrent depression, especially in those with the most severe residual symptoms, a meta-analysis showed. Patients receiving MBCT had a significantly reduced risk of depressive relapse within … Continue reading →

More patients with serious psychological distress had insurance coverage following the Affordable Care Act, but that didn’t change whether they’d seen a healthcare professional recently, researchers reported. In an analysis of data from the National Health Interview Survey (NHIS), the … Continue reading →